Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry labeled v3.7.0 has been added to the study record history, representing the latest update to the record. The previous revision v3.6.6 has been removed from the list.SummaryDifference0.1%

- Check47 days agoChange DetectedNew latest revision entry v3.6.6 has been added to the Study Record History, replacing the prior v3.6.5. This documents an updated revision of the record on ClinicalTrials.gov.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry (v3.6.5) appears, replacing the previous revision (v3.6.4) in the study record history. This reflects a maintenance update to the page's revision metadata.SummaryDifference0.1%

- Check83 days agoChange DetectedThe study record history now shows Revision: v3.6.4 as the latest entry, replacing v3.6.3. This indicates a site update and does not modify the study details or results.SummaryDifference0.1%

- Check104 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the Study Record History, and the previous v3.6.2 entry was removed. This reflects an update to the page's revision history in the study's record.SummaryDifference0.1%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.